Digital Therapeutics – US and EU Specific Frameworks – Part 2
By: Ambika Subramanian, Meherpreet Saluja
Digital Therapeutics has the potential to revolutionize the clinical and financial management of chronic diseases, which are of great importance to public and private health emergencies. They also have the potential to become the first therapeutic option that every doctor offers to each of their patients who have a chronic illness and/or dependency.
Part 2 of this white paper delves deeper into the regulatory and reimbursement frameworks prevalent in the US and EU.